Joint Meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Notice of Meeting

Summary

The FDA will host a joint meeting of the Antiviral Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee to discuss the safety and efficacy of a new antiviral medication. The meeting will take place on March 15, 2023, at the FDA White Oak Campus in Silver Spring, Maryland.